Global Vaccine Adjuvants Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Summary
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
According to APO Research, The global Vaccine Adjuvants market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Vaccine Adjuvants include GSK, CSL Limited, Croda, SEPPIC, Novavax, SPI Pharma, Phibro, SDA BIO and Invivogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Vaccine Adjuvants, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Vaccine Adjuvants, also provides the sales of main regions and countries. Of the upcoming market potential for Vaccine Adjuvants, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Vaccine Adjuvants sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Vaccine Adjuvants market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Vaccine Adjuvants sales, projected growth trends, production technology, application and end-user industry.
Vaccine Adjuvants segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccine Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Adjuvants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Vaccine Adjuvants market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccine Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vaccine Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Vaccine Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
According to APO Research, The global Vaccine Adjuvants market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Vaccine Adjuvants include GSK, CSL Limited, Croda, SEPPIC, Novavax, SPI Pharma, Phibro, SDA BIO and Invivogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Vaccine Adjuvants, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Vaccine Adjuvants, also provides the sales of main regions and countries. Of the upcoming market potential for Vaccine Adjuvants, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Vaccine Adjuvants sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Vaccine Adjuvants market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Vaccine Adjuvants sales, projected growth trends, production technology, application and end-user industry.
Vaccine Adjuvants segment by Company
- GSK
- CSL Limited
- Croda
- SEPPIC
- Novavax
- SPI Pharma
- Phibro
- SDA BIO
- Invivogen
- Tj Kaiwei
- OZ Biosciences
- Brenntag Biosector
- MVP Laboratories
- Zhuoyue
- Aphios
- Aluminum Adjuvant
- Emulsions Adjuvant
- Others
- Human Vaccine
- Veterinary Vaccine
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccine Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Adjuvants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Vaccine Adjuvants market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccine Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vaccine Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Vaccine Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Vaccine Adjuvants Market Size, 2019 VS 2023 VS 2030
1.3 Global Vaccine Adjuvants Market Size Estimates and Forecasts (2019-2030)
1.4 Global Vaccine Adjuvants Sales Estimates and Forecasts (2019-2030)
1.5 Global Vaccine Adjuvants Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL VACCINE ADJUVANTS MARKET DYNAMICS
2.1 Vaccine Adjuvants Industry Trends
2.2 Vaccine Adjuvants Industry Drivers
2.3 Vaccine Adjuvants Industry Opportunities and Challenges
2.4 Vaccine Adjuvants Industry Restraints
3 VACCINE ADJUVANTS MARKET BY MANUFACTURERS
3.1 Global Vaccine Adjuvants Revenue by Manufacturers (2019-2024)
3.2 Global Vaccine Adjuvants Sales by Manufacturers (2019-2024)
3.3 Global Vaccine Adjuvants Average Sales Price by Manufacturers (2019-2024)
3.4 Global Vaccine Adjuvants Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Vaccine Adjuvants Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Vaccine Adjuvants Manufacturers, Product Type & Application
3.7 Global Vaccine Adjuvants Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Vaccine Adjuvants Market CR5 and HHI
3.8.2 Global Top 5 and 10 Vaccine Adjuvants Players Market Share by Revenue in 2023
3.8.3 2023 Vaccine Adjuvants Tier 1, Tier 2, and Tier
4 VACCINE ADJUVANTS MARKET BY TYPE
4.1 Vaccine Adjuvants Type Introduction
4.1.1 Aluminum Adjuvant
4.1.2 Emulsions Adjuvant
4.1.3 Others
4.2 Global Vaccine Adjuvants Sales by Type
4.2.1 Global Vaccine Adjuvants Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Vaccine Adjuvants Sales by Type (2019-2030)
4.2.3 Global Vaccine Adjuvants Sales Market Share by Type (2019-2030)
4.3 Global Vaccine Adjuvants Revenue by Type
4.3.1 Global Vaccine Adjuvants Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Vaccine Adjuvants Revenue by Type (2019-2030)
4.3.3 Global Vaccine Adjuvants Revenue Market Share by Type (2019-2030)
5 VACCINE ADJUVANTS MARKET BY APPLICATION
5.1 Vaccine Adjuvants Application Introduction
5.1.1 Human Vaccine
5.1.2 Veterinary Vaccine
5.2 Global Vaccine Adjuvants Sales by Application
5.2.1 Global Vaccine Adjuvants Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Vaccine Adjuvants Sales by Application (2019-2030)
5.2.3 Global Vaccine Adjuvants Sales Market Share by Application (2019-2030)
5.3 Global Vaccine Adjuvants Revenue by Application
5.3.1 Global Vaccine Adjuvants Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Vaccine Adjuvants Revenue by Application (2019-2030)
5.3.3 Global Vaccine Adjuvants Revenue Market Share by Application (2019-2030)
6 GLOBAL VACCINE ADJUVANTS SALES BY REGION
6.1 Global Vaccine Adjuvants Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Vaccine Adjuvants Sales by Region (2019-2030)
6.2.1 Global Vaccine Adjuvants Sales by Region (2019-2024)
6.2.2 Global Vaccine Adjuvants Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Vaccine Adjuvants Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Vaccine Adjuvants Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Vaccine Adjuvants Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Vaccine Adjuvants Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL VACCINE ADJUVANTS REVENUE BY REGION
7.1 Global Vaccine Adjuvants Revenue by Region
7.1.1 Global Vaccine Adjuvants Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Vaccine Adjuvants Revenue by Region (2019-2024)
7.1.3 Global Vaccine Adjuvants Revenue by Region (2025-2030)
7.1.4 Global Vaccine Adjuvants Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Vaccine Adjuvants Revenue (2019-2030)
7.2.2 North America Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Vaccine Adjuvants Revenue (2019-2030)
7.3.2 Europe Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Vaccine Adjuvants Revenue (2019-2030)
7.4.2 Asia-Pacific Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Vaccine Adjuvants Revenue (2019-2030)
7.5.2 LAMEA Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 GSK
8.1.1 GSK Comapny Information
8.1.2 GSK Business Overview
8.1.3 GSK Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 GSK Vaccine Adjuvants Product Portfolio
8.1.5 GSK Recent Developments
8.2 CSL Limited
8.2.1 CSL Limited Comapny Information
8.2.2 CSL Limited Business Overview
8.2.3 CSL Limited Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 CSL Limited Vaccine Adjuvants Product Portfolio
8.2.5 CSL Limited Recent Developments
8.3 Croda
8.3.1 Croda Comapny Information
8.3.2 Croda Business Overview
8.3.3 Croda Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Croda Vaccine Adjuvants Product Portfolio
8.3.5 Croda Recent Developments
8.4 SEPPIC
8.4.1 SEPPIC Comapny Information
8.4.2 SEPPIC Business Overview
8.4.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 SEPPIC Vaccine Adjuvants Product Portfolio
8.4.5 SEPPIC Recent Developments
8.5 Novavax
8.5.1 Novavax Comapny Information
8.5.2 Novavax Business Overview
8.5.3 Novavax Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Novavax Vaccine Adjuvants Product Portfolio
8.5.5 Novavax Recent Developments
8.6 SPI Pharma
8.6.1 SPI Pharma Comapny Information
8.6.2 SPI Pharma Business Overview
8.6.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 SPI Pharma Vaccine Adjuvants Product Portfolio
8.6.5 SPI Pharma Recent Developments
8.7 Phibro
8.7.1 Phibro Comapny Information
8.7.2 Phibro Business Overview
8.7.3 Phibro Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Phibro Vaccine Adjuvants Product Portfolio
8.7.5 Phibro Recent Developments
8.8 SDA BIO
8.8.1 SDA BIO Comapny Information
8.8.2 SDA BIO Business Overview
8.8.3 SDA BIO Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 SDA BIO Vaccine Adjuvants Product Portfolio
8.8.5 SDA BIO Recent Developments
8.9 Invivogen
8.9.1 Invivogen Comapny Information
8.9.2 Invivogen Business Overview
8.9.3 Invivogen Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Invivogen Vaccine Adjuvants Product Portfolio
8.9.5 Invivogen Recent Developments
8.10 Tj Kaiwei
8.10.1 Tj Kaiwei Comapny Information
8.10.2 Tj Kaiwei Business Overview
8.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Tj Kaiwei Vaccine Adjuvants Product Portfolio
8.10.5 Tj Kaiwei Recent Developments
8.11 OZ Biosciences
8.11.1 OZ Biosciences Comapny Information
8.11.2 OZ Biosciences Business Overview
8.11.3 OZ Biosciences Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 OZ Biosciences Vaccine Adjuvants Product Portfolio
8.11.5 OZ Biosciences Recent Developments
8.12 Brenntag Biosector
8.12.1 Brenntag Biosector Comapny Information
8.12.2 Brenntag Biosector Business Overview
8.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Brenntag Biosector Vaccine Adjuvants Product Portfolio
8.12.5 Brenntag Biosector Recent Developments
8.13 MVP Laboratories
8.13.1 MVP Laboratories Comapny Information
8.13.2 MVP Laboratories Business Overview
8.13.3 MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 MVP Laboratories Vaccine Adjuvants Product Portfolio
8.13.5 MVP Laboratories Recent Developments
8.14 Zhuoyue
8.14.1 Zhuoyue Comapny Information
8.14.2 Zhuoyue Business Overview
8.14.3 Zhuoyue Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 Zhuoyue Vaccine Adjuvants Product Portfolio
8.14.5 Zhuoyue Recent Developments
8.15 Aphios
8.15.1 Aphios Comapny Information
8.15.2 Aphios Business Overview
8.15.3 Aphios Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 Aphios Vaccine Adjuvants Product Portfolio
8.15.5 Aphios Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Vaccine Adjuvants Value Chain Analysis
9.1.1 Vaccine Adjuvants Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Vaccine Adjuvants Production Mode & Process
9.2 Vaccine Adjuvants Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Vaccine Adjuvants Distributors
9.2.3 Vaccine Adjuvants Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Vaccine Adjuvants Market Size, 2019 VS 2023 VS 2030
1.3 Global Vaccine Adjuvants Market Size Estimates and Forecasts (2019-2030)
1.4 Global Vaccine Adjuvants Sales Estimates and Forecasts (2019-2030)
1.5 Global Vaccine Adjuvants Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL VACCINE ADJUVANTS MARKET DYNAMICS
2.1 Vaccine Adjuvants Industry Trends
2.2 Vaccine Adjuvants Industry Drivers
2.3 Vaccine Adjuvants Industry Opportunities and Challenges
2.4 Vaccine Adjuvants Industry Restraints
3 VACCINE ADJUVANTS MARKET BY MANUFACTURERS
3.1 Global Vaccine Adjuvants Revenue by Manufacturers (2019-2024)
3.2 Global Vaccine Adjuvants Sales by Manufacturers (2019-2024)
3.3 Global Vaccine Adjuvants Average Sales Price by Manufacturers (2019-2024)
3.4 Global Vaccine Adjuvants Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Vaccine Adjuvants Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Vaccine Adjuvants Manufacturers, Product Type & Application
3.7 Global Vaccine Adjuvants Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Vaccine Adjuvants Market CR5 and HHI
3.8.2 Global Top 5 and 10 Vaccine Adjuvants Players Market Share by Revenue in 2023
3.8.3 2023 Vaccine Adjuvants Tier 1, Tier 2, and Tier
4 VACCINE ADJUVANTS MARKET BY TYPE
4.1 Vaccine Adjuvants Type Introduction
4.1.1 Aluminum Adjuvant
4.1.2 Emulsions Adjuvant
4.1.3 Others
4.2 Global Vaccine Adjuvants Sales by Type
4.2.1 Global Vaccine Adjuvants Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Vaccine Adjuvants Sales by Type (2019-2030)
4.2.3 Global Vaccine Adjuvants Sales Market Share by Type (2019-2030)
4.3 Global Vaccine Adjuvants Revenue by Type
4.3.1 Global Vaccine Adjuvants Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Vaccine Adjuvants Revenue by Type (2019-2030)
4.3.3 Global Vaccine Adjuvants Revenue Market Share by Type (2019-2030)
5 VACCINE ADJUVANTS MARKET BY APPLICATION
5.1 Vaccine Adjuvants Application Introduction
5.1.1 Human Vaccine
5.1.2 Veterinary Vaccine
5.2 Global Vaccine Adjuvants Sales by Application
5.2.1 Global Vaccine Adjuvants Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Vaccine Adjuvants Sales by Application (2019-2030)
5.2.3 Global Vaccine Adjuvants Sales Market Share by Application (2019-2030)
5.3 Global Vaccine Adjuvants Revenue by Application
5.3.1 Global Vaccine Adjuvants Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Vaccine Adjuvants Revenue by Application (2019-2030)
5.3.3 Global Vaccine Adjuvants Revenue Market Share by Application (2019-2030)
6 GLOBAL VACCINE ADJUVANTS SALES BY REGION
6.1 Global Vaccine Adjuvants Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Vaccine Adjuvants Sales by Region (2019-2030)
6.2.1 Global Vaccine Adjuvants Sales by Region (2019-2024)
6.2.2 Global Vaccine Adjuvants Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Vaccine Adjuvants Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Vaccine Adjuvants Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Vaccine Adjuvants Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Vaccine Adjuvants Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL VACCINE ADJUVANTS REVENUE BY REGION
7.1 Global Vaccine Adjuvants Revenue by Region
7.1.1 Global Vaccine Adjuvants Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Vaccine Adjuvants Revenue by Region (2019-2024)
7.1.3 Global Vaccine Adjuvants Revenue by Region (2025-2030)
7.1.4 Global Vaccine Adjuvants Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Vaccine Adjuvants Revenue (2019-2030)
7.2.2 North America Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Vaccine Adjuvants Revenue (2019-2030)
7.3.2 Europe Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Vaccine Adjuvants Revenue (2019-2030)
7.4.2 Asia-Pacific Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Vaccine Adjuvants Revenue (2019-2030)
7.5.2 LAMEA Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 GSK
8.1.1 GSK Comapny Information
8.1.2 GSK Business Overview
8.1.3 GSK Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 GSK Vaccine Adjuvants Product Portfolio
8.1.5 GSK Recent Developments
8.2 CSL Limited
8.2.1 CSL Limited Comapny Information
8.2.2 CSL Limited Business Overview
8.2.3 CSL Limited Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 CSL Limited Vaccine Adjuvants Product Portfolio
8.2.5 CSL Limited Recent Developments
8.3 Croda
8.3.1 Croda Comapny Information
8.3.2 Croda Business Overview
8.3.3 Croda Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Croda Vaccine Adjuvants Product Portfolio
8.3.5 Croda Recent Developments
8.4 SEPPIC
8.4.1 SEPPIC Comapny Information
8.4.2 SEPPIC Business Overview
8.4.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 SEPPIC Vaccine Adjuvants Product Portfolio
8.4.5 SEPPIC Recent Developments
8.5 Novavax
8.5.1 Novavax Comapny Information
8.5.2 Novavax Business Overview
8.5.3 Novavax Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Novavax Vaccine Adjuvants Product Portfolio
8.5.5 Novavax Recent Developments
8.6 SPI Pharma
8.6.1 SPI Pharma Comapny Information
8.6.2 SPI Pharma Business Overview
8.6.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 SPI Pharma Vaccine Adjuvants Product Portfolio
8.6.5 SPI Pharma Recent Developments
8.7 Phibro
8.7.1 Phibro Comapny Information
8.7.2 Phibro Business Overview
8.7.3 Phibro Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Phibro Vaccine Adjuvants Product Portfolio
8.7.5 Phibro Recent Developments
8.8 SDA BIO
8.8.1 SDA BIO Comapny Information
8.8.2 SDA BIO Business Overview
8.8.3 SDA BIO Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 SDA BIO Vaccine Adjuvants Product Portfolio
8.8.5 SDA BIO Recent Developments
8.9 Invivogen
8.9.1 Invivogen Comapny Information
8.9.2 Invivogen Business Overview
8.9.3 Invivogen Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Invivogen Vaccine Adjuvants Product Portfolio
8.9.5 Invivogen Recent Developments
8.10 Tj Kaiwei
8.10.1 Tj Kaiwei Comapny Information
8.10.2 Tj Kaiwei Business Overview
8.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Tj Kaiwei Vaccine Adjuvants Product Portfolio
8.10.5 Tj Kaiwei Recent Developments
8.11 OZ Biosciences
8.11.1 OZ Biosciences Comapny Information
8.11.2 OZ Biosciences Business Overview
8.11.3 OZ Biosciences Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 OZ Biosciences Vaccine Adjuvants Product Portfolio
8.11.5 OZ Biosciences Recent Developments
8.12 Brenntag Biosector
8.12.1 Brenntag Biosector Comapny Information
8.12.2 Brenntag Biosector Business Overview
8.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Brenntag Biosector Vaccine Adjuvants Product Portfolio
8.12.5 Brenntag Biosector Recent Developments
8.13 MVP Laboratories
8.13.1 MVP Laboratories Comapny Information
8.13.2 MVP Laboratories Business Overview
8.13.3 MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 MVP Laboratories Vaccine Adjuvants Product Portfolio
8.13.5 MVP Laboratories Recent Developments
8.14 Zhuoyue
8.14.1 Zhuoyue Comapny Information
8.14.2 Zhuoyue Business Overview
8.14.3 Zhuoyue Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 Zhuoyue Vaccine Adjuvants Product Portfolio
8.14.5 Zhuoyue Recent Developments
8.15 Aphios
8.15.1 Aphios Comapny Information
8.15.2 Aphios Business Overview
8.15.3 Aphios Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 Aphios Vaccine Adjuvants Product Portfolio
8.15.5 Aphios Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Vaccine Adjuvants Value Chain Analysis
9.1.1 Vaccine Adjuvants Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Vaccine Adjuvants Production Mode & Process
9.2 Vaccine Adjuvants Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Vaccine Adjuvants Distributors
9.2.3 Vaccine Adjuvants Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
LIST OF TABLES
Table 1. Vaccine Adjuvants Industry Trends
Table 2. Vaccine Adjuvants Industry Drivers
Table 3. Vaccine Adjuvants Industry Opportunities and Challenges
Table 4. Vaccine Adjuvants Industry Restraints
Table 5. Global Vaccine Adjuvants Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Vaccine Adjuvants Sales by Manufacturers (MT) & (2019-2024)
Table 8. Global Vaccine Adjuvants Sales Market Share by Manufacturers
Table 9. Global Vaccine Adjuvants Average Sales Price (USD/Kg) of Manufacturers (2019-2024)
Table 10. Global Vaccine Adjuvants Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Vaccine Adjuvants Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Vaccine Adjuvants Manufacturers, Product Type & Application
Table 13. Global Vaccine Adjuvants Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Vaccine Adjuvants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Aluminum Adjuvant
Table 17. Major Manufacturers of Emulsions Adjuvant
Table 18. Major Manufacturers of Others
Table 19. Global Vaccine Adjuvants Sales by Type 2019 VS 2023 VS 2030 (MT)
Table 20. Global Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 21. Global Vaccine Adjuvants Sales by Type (2025-2030) & (MT)
Table 22. Global Vaccine Adjuvants Sales Market Share by Type (2019-2024)
Table 23. Global Vaccine Adjuvants Sales Market Share by Type (2025-2030)
Table 24. Global Vaccine Adjuvants Revenue by Type 2019 VS 2023 VS 2030 (MT)
Table 25. Global Vaccine Adjuvants Revenue by Type (2019-2024) & (MT)
Table 26. Global Vaccine Adjuvants Revenue by Type (2025-2030) & (MT)
Table 27. Global Vaccine Adjuvants Revenue Market Share by Type (2019-2024)
Table 28. Global Vaccine Adjuvants Revenue Market Share by Type (2025-2030)
Table 29. Major Manufacturers of Human Vaccine
Table 30. Major Manufacturers of Veterinary Vaccine
Table 31. Global Vaccine Adjuvants Sales by Application 2019 VS 2023 VS 2030 (MT)
Table 32. Global Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 33. Global Vaccine Adjuvants Sales by Application (2025-2030) & (MT)
Table 34. Global Vaccine Adjuvants Sales Market Share by Application (2019-2024)
Table 35. Global Vaccine Adjuvants Sales Market Share by Application (2025-2030)
Table 36. Global Vaccine Adjuvants Revenue by Application 2019 VS 2023 VS 2030 (MT)
Table 37. Global Vaccine Adjuvants Revenue by Application (2019-2024) & (MT)
Table 38. Global Vaccine Adjuvants Revenue by Application (2025-2030) & (MT)
Table 39. Global Vaccine Adjuvants Revenue Market Share by Application (2019-2024)
Table 40. Global Vaccine Adjuvants Revenue Market Share by Application (2025-2030)
Table 41. Global Vaccine Adjuvants Sales by Region: 2019 VS 2023 VS 2030 (MT)
Table 42. Global Vaccine Adjuvants Sales by Region (2019-2024) & (MT)
Table 43. Global Vaccine Adjuvants Sales Market Share by Region (2019-2024)
Table 44. Global Vaccine Adjuvants Sales Forecasted by Region (2025-2030) & (MT)
Table 45. Global Vaccine Adjuvants Sales Forecasted Market Share by Region (2025-2030)
Table 46. North America Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (MT)
Table 47. North America Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 48. North America Vaccine Adjuvants Sales by Country (2025-2030) & (MT)
Table 49. Europe Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (MT)
Table 50. Europe Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 51. Europe Vaccine Adjuvants Sales by Country (2025-2030) & (MT)
Table 52. Asia Pacific Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (MT)
Table 53. Asia Pacific Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 54. Asia Pacific Vaccine Adjuvants Sales by Country (2025-2030) & (MT)
Table 55. LAMEA Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (MT)
Table 56. LAMEA Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 57. LAMEA Vaccine Adjuvants Sales by Country (2025-2030) & (MT)
Table 58. Global Vaccine Adjuvants Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. Global Vaccine Adjuvants Revenue by Region (2019-2024) & (US$ Million)
Table 60. Global Vaccine Adjuvants Revenue by Region (2025-2030) & (US$ Million)
Table 61. Global Vaccine Adjuvants Revenue Market Share by Region (2019-2024)
Table 62. Global Vaccine Adjuvants Revenue Market Share by Region (2025-2030)
Table 63. GSK Company Information
Table 64. GSK Business Overview
Table 65. GSK Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 66. GSK Vaccine Adjuvants Product Portfolio
Table 67. GSK Recent Development
Table 68. CSL Limited Company Information
Table 69. CSL Limited Business Overview
Table 70. CSL Limited Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 71. CSL Limited Vaccine Adjuvants Product Portfolio
Table 72. CSL Limited Recent Development
Table 73. Croda Company Information
Table 74. Croda Business Overview
Table 75. Croda Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 76. Croda Vaccine Adjuvants Product Portfolio
Table 77. Croda Recent Development
Table 78. SEPPIC Company Information
Table 79. SEPPIC Business Overview
Table 80. SEPPIC Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 81. SEPPIC Vaccine Adjuvants Product Portfolio
Table 82. SEPPIC Recent Development
Table 83. Novavax Company Information
Table 84. Novavax Business Overview
Table 85. Novavax Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 86. Novavax Vaccine Adjuvants Product Portfolio
Table 87. Novavax Recent Development
Table 88. SPI Pharma Company Information
Table 89. SPI Pharma Business Overview
Table 90. SPI Pharma Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 91. SPI Pharma Vaccine Adjuvants Product Portfolio
Table 92. SPI Pharma Recent Development
Table 93. Phibro Company Information
Table 94. Phibro Business Overview
Table 95. Phibro Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 96. Phibro Vaccine Adjuvants Product Portfolio
Table 97. Phibro Recent Development
Table 98. SDA BIO Company Information
Table 99. SDA BIO Business Overview
Table 100. SDA BIO Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 101. SDA BIO Vaccine Adjuvants Product Portfolio
Table 102. SDA BIO Recent Development
Table 103. Invivogen Company Information
Table 104. Invivogen Business Overview
Table 105. Invivogen Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 106. Invivogen Vaccine Adjuvants Product Portfolio
Table 107. Invivogen Recent Development
Table 108. Tj Kaiwei Company Information
Table 109. Tj Kaiwei Business Overview
Table 110. Tj Kaiwei Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 111. Tj Kaiwei Vaccine Adjuvants Product Portfolio
Table 112. Tj Kaiwei Recent Development
Table 113. OZ Biosciences Company Information
Table 114. OZ Biosciences Business Overview
Table 115. OZ Biosciences Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 116. OZ Biosciences Vaccine Adjuvants Product Portfolio
Table 117. OZ Biosciences Recent Development
Table 118. Brenntag Biosector Company Information
Table 119. Brenntag Biosector Business Overview
Table 120. Brenntag Biosector Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 121. Brenntag Biosector Vaccine Adjuvants Product Portfolio
Table 122. Brenntag Biosector Recent Development
Table 123. MVP Laboratories Company Information
Table 124. MVP Laboratories Business Overview
Table 125. MVP Laboratories Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 126. MVP Laboratories Vaccine Adjuvants Product Portfolio
Table 127. MVP Laboratories Recent Development
Table 128. Zhuoyue Company Information
Table 129. Zhuoyue Business Overview
Table 130. Zhuoyue Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 131. Zhuoyue Vaccine Adjuvants Product Portfolio
Table 132. Zhuoyue Recent Development
Table 133. Aphios Company Information
Table 134. Aphios Business Overview
Table 135. Aphios Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 136. Aphios Vaccine Adjuvants Product Portfolio
Table 137. Aphios Recent Development
Table 138. Key Raw Materials
Table 139. Raw Materials Key Suppliers
Table 140. Vaccine Adjuvants Distributors List
Table 141. Vaccine Adjuvants Customers List
Table 142. Research Programs/Design for This Report
Table 143. Authors List of This Report
Table 144. Secondary Sources
Table 145. Primary Sources
Table 1. Vaccine Adjuvants Industry Trends
Table 2. Vaccine Adjuvants Industry Drivers
Table 3. Vaccine Adjuvants Industry Opportunities and Challenges
Table 4. Vaccine Adjuvants Industry Restraints
Table 5. Global Vaccine Adjuvants Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Vaccine Adjuvants Sales by Manufacturers (MT) & (2019-2024)
Table 8. Global Vaccine Adjuvants Sales Market Share by Manufacturers
Table 9. Global Vaccine Adjuvants Average Sales Price (USD/Kg) of Manufacturers (2019-2024)
Table 10. Global Vaccine Adjuvants Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Vaccine Adjuvants Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Vaccine Adjuvants Manufacturers, Product Type & Application
Table 13. Global Vaccine Adjuvants Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Vaccine Adjuvants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Aluminum Adjuvant
Table 17. Major Manufacturers of Emulsions Adjuvant
Table 18. Major Manufacturers of Others
Table 19. Global Vaccine Adjuvants Sales by Type 2019 VS 2023 VS 2030 (MT)
Table 20. Global Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 21. Global Vaccine Adjuvants Sales by Type (2025-2030) & (MT)
Table 22. Global Vaccine Adjuvants Sales Market Share by Type (2019-2024)
Table 23. Global Vaccine Adjuvants Sales Market Share by Type (2025-2030)
Table 24. Global Vaccine Adjuvants Revenue by Type 2019 VS 2023 VS 2030 (MT)
Table 25. Global Vaccine Adjuvants Revenue by Type (2019-2024) & (MT)
Table 26. Global Vaccine Adjuvants Revenue by Type (2025-2030) & (MT)
Table 27. Global Vaccine Adjuvants Revenue Market Share by Type (2019-2024)
Table 28. Global Vaccine Adjuvants Revenue Market Share by Type (2025-2030)
Table 29. Major Manufacturers of Human Vaccine
Table 30. Major Manufacturers of Veterinary Vaccine
Table 31. Global Vaccine Adjuvants Sales by Application 2019 VS 2023 VS 2030 (MT)
Table 32. Global Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 33. Global Vaccine Adjuvants Sales by Application (2025-2030) & (MT)
Table 34. Global Vaccine Adjuvants Sales Market Share by Application (2019-2024)
Table 35. Global Vaccine Adjuvants Sales Market Share by Application (2025-2030)
Table 36. Global Vaccine Adjuvants Revenue by Application 2019 VS 2023 VS 2030 (MT)
Table 37. Global Vaccine Adjuvants Revenue by Application (2019-2024) & (MT)
Table 38. Global Vaccine Adjuvants Revenue by Application (2025-2030) & (MT)
Table 39. Global Vaccine Adjuvants Revenue Market Share by Application (2019-2024)
Table 40. Global Vaccine Adjuvants Revenue Market Share by Application (2025-2030)
Table 41. Global Vaccine Adjuvants Sales by Region: 2019 VS 2023 VS 2030 (MT)
Table 42. Global Vaccine Adjuvants Sales by Region (2019-2024) & (MT)
Table 43. Global Vaccine Adjuvants Sales Market Share by Region (2019-2024)
Table 44. Global Vaccine Adjuvants Sales Forecasted by Region (2025-2030) & (MT)
Table 45. Global Vaccine Adjuvants Sales Forecasted Market Share by Region (2025-2030)
Table 46. North America Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (MT)
Table 47. North America Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 48. North America Vaccine Adjuvants Sales by Country (2025-2030) & (MT)
Table 49. Europe Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (MT)
Table 50. Europe Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 51. Europe Vaccine Adjuvants Sales by Country (2025-2030) & (MT)
Table 52. Asia Pacific Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (MT)
Table 53. Asia Pacific Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 54. Asia Pacific Vaccine Adjuvants Sales by Country (2025-2030) & (MT)
Table 55. LAMEA Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (MT)
Table 56. LAMEA Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 57. LAMEA Vaccine Adjuvants Sales by Country (2025-2030) & (MT)
Table 58. Global Vaccine Adjuvants Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. Global Vaccine Adjuvants Revenue by Region (2019-2024) & (US$ Million)
Table 60. Global Vaccine Adjuvants Revenue by Region (2025-2030) & (US$ Million)
Table 61. Global Vaccine Adjuvants Revenue Market Share by Region (2019-2024)
Table 62. Global Vaccine Adjuvants Revenue Market Share by Region (2025-2030)
Table 63. GSK Company Information
Table 64. GSK Business Overview
Table 65. GSK Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 66. GSK Vaccine Adjuvants Product Portfolio
Table 67. GSK Recent Development
Table 68. CSL Limited Company Information
Table 69. CSL Limited Business Overview
Table 70. CSL Limited Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 71. CSL Limited Vaccine Adjuvants Product Portfolio
Table 72. CSL Limited Recent Development
Table 73. Croda Company Information
Table 74. Croda Business Overview
Table 75. Croda Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 76. Croda Vaccine Adjuvants Product Portfolio
Table 77. Croda Recent Development
Table 78. SEPPIC Company Information
Table 79. SEPPIC Business Overview
Table 80. SEPPIC Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 81. SEPPIC Vaccine Adjuvants Product Portfolio
Table 82. SEPPIC Recent Development
Table 83. Novavax Company Information
Table 84. Novavax Business Overview
Table 85. Novavax Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 86. Novavax Vaccine Adjuvants Product Portfolio
Table 87. Novavax Recent Development
Table 88. SPI Pharma Company Information
Table 89. SPI Pharma Business Overview
Table 90. SPI Pharma Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 91. SPI Pharma Vaccine Adjuvants Product Portfolio
Table 92. SPI Pharma Recent Development
Table 93. Phibro Company Information
Table 94. Phibro Business Overview
Table 95. Phibro Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 96. Phibro Vaccine Adjuvants Product Portfolio
Table 97. Phibro Recent Development
Table 98. SDA BIO Company Information
Table 99. SDA BIO Business Overview
Table 100. SDA BIO Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 101. SDA BIO Vaccine Adjuvants Product Portfolio
Table 102. SDA BIO Recent Development
Table 103. Invivogen Company Information
Table 104. Invivogen Business Overview
Table 105. Invivogen Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 106. Invivogen Vaccine Adjuvants Product Portfolio
Table 107. Invivogen Recent Development
Table 108. Tj Kaiwei Company Information
Table 109. Tj Kaiwei Business Overview
Table 110. Tj Kaiwei Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 111. Tj Kaiwei Vaccine Adjuvants Product Portfolio
Table 112. Tj Kaiwei Recent Development
Table 113. OZ Biosciences Company Information
Table 114. OZ Biosciences Business Overview
Table 115. OZ Biosciences Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 116. OZ Biosciences Vaccine Adjuvants Product Portfolio
Table 117. OZ Biosciences Recent Development
Table 118. Brenntag Biosector Company Information
Table 119. Brenntag Biosector Business Overview
Table 120. Brenntag Biosector Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 121. Brenntag Biosector Vaccine Adjuvants Product Portfolio
Table 122. Brenntag Biosector Recent Development
Table 123. MVP Laboratories Company Information
Table 124. MVP Laboratories Business Overview
Table 125. MVP Laboratories Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 126. MVP Laboratories Vaccine Adjuvants Product Portfolio
Table 127. MVP Laboratories Recent Development
Table 128. Zhuoyue Company Information
Table 129. Zhuoyue Business Overview
Table 130. Zhuoyue Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 131. Zhuoyue Vaccine Adjuvants Product Portfolio
Table 132. Zhuoyue Recent Development
Table 133. Aphios Company Information
Table 134. Aphios Business Overview
Table 135. Aphios Vaccine Adjuvants Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 136. Aphios Vaccine Adjuvants Product Portfolio
Table 137. Aphios Recent Development
Table 138. Key Raw Materials
Table 139. Raw Materials Key Suppliers
Table 140. Vaccine Adjuvants Distributors List
Table 141. Vaccine Adjuvants Customers List
Table 142. Research Programs/Design for This Report
Table 143. Authors List of This Report
Table 144. Secondary Sources
Table 145. Primary Sources
LIST OF FIGURES
Figure 1. Vaccine Adjuvants Product Picture
Figure 2. Global Vaccine Adjuvants Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Vaccine Adjuvants Market Size (2019-2030) & (US$ Million)
Figure 4. Global Vaccine Adjuvants Sales (2019-2030) & (MT)
Figure 5. Global Vaccine Adjuvants Average Price (USD/Kg) & (2019-2030)
Figure 6. Global Top 5 and 10 Vaccine Adjuvants Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Aluminum Adjuvant Picture
Figure 9. Emulsions Adjuvant Picture
Figure 10. Others Picture
Figure 11. Global Vaccine Adjuvants Sales by Type (2019 VS 2023 VS 2030) & (MT)
Figure 12. Global Vaccine Adjuvants Sales Market Share 2019 VS 2023 VS 2030
Figure 13. Global Vaccine Adjuvants Sales Market Share by Type (2019-2030)
Figure 14. Global Vaccine Adjuvants Revenue by Type (2019 VS 2023 VS 2030) & (MT)
Figure 15. Global Vaccine Adjuvants Revenue Market Share 2019 VS 2023 VS 2030
Figure 16. Global Vaccine Adjuvants Revenue Market Share by Type (2019-2030)
Figure 17. Human Vaccine Picture
Figure 18. Veterinary Vaccine Picture
Figure 19. Global Vaccine Adjuvants Sales by Application (2019 VS 2023 VS 2030) & (MT)
Figure 20. Global Vaccine Adjuvants Sales Market Share 2019 VS 2023 VS 2030
Figure 21. Global Vaccine Adjuvants Sales Market Share by Application (2019-2030)
Figure 22. Global Vaccine Adjuvants Revenue by Application (2019 VS 2023 VS 2030) & (MT)
Figure 23. Global Vaccine Adjuvants Revenue Market Share 2019 VS 2023 VS 2030
Figure 24. Global Vaccine Adjuvants Revenue Market Share by Application (2019-2030)
Figure 25. North America Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 26. North America Vaccine Adjuvants Sales Market Share by Country (2019-2030)
Figure 27. U.S. Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 28. Canada Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 29. Europe Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 30. Europe Vaccine Adjuvants Sales Market Share by Country (2019-2030)
Figure 31. Germany Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 32. France Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 33. U.K. Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 34. Italy Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 35. Netherlands Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 36. Asia Pacific Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 37. Asia Pacific Vaccine Adjuvants Sales Market Share by Country (2019-2030)
Figure 38. China Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 39. Japan Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 40. South Korea Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 41. Southeast Asia Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 42. India Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 43. Australia Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 44. LAMEA Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 45. LAMEA Vaccine Adjuvants Sales Market Share by Country (2019-2030)
Figure 46. Mexico Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 47. Brazil Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 48. Turkey Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 49. GCC Countries Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 50. Global Vaccine Adjuvants Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Global Vaccine Adjuvants Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 52. North America Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Figure 53. North America Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 54. Europe Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Figure 55. Europe Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 56. Asia-Pacific Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Figure 57. Asia-Pacific Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 58. LAMEA Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Figure 59. LAMEA Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 60. Vaccine Adjuvants Value Chain
Figure 61. Manufacturing Cost Structure
Figure 62. Vaccine Adjuvants Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Years Considered
Figure 66. Research Process
Figure 67. Key Executives Interviewed
Figure 1. Vaccine Adjuvants Product Picture
Figure 2. Global Vaccine Adjuvants Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Vaccine Adjuvants Market Size (2019-2030) & (US$ Million)
Figure 4. Global Vaccine Adjuvants Sales (2019-2030) & (MT)
Figure 5. Global Vaccine Adjuvants Average Price (USD/Kg) & (2019-2030)
Figure 6. Global Top 5 and 10 Vaccine Adjuvants Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Aluminum Adjuvant Picture
Figure 9. Emulsions Adjuvant Picture
Figure 10. Others Picture
Figure 11. Global Vaccine Adjuvants Sales by Type (2019 VS 2023 VS 2030) & (MT)
Figure 12. Global Vaccine Adjuvants Sales Market Share 2019 VS 2023 VS 2030
Figure 13. Global Vaccine Adjuvants Sales Market Share by Type (2019-2030)
Figure 14. Global Vaccine Adjuvants Revenue by Type (2019 VS 2023 VS 2030) & (MT)
Figure 15. Global Vaccine Adjuvants Revenue Market Share 2019 VS 2023 VS 2030
Figure 16. Global Vaccine Adjuvants Revenue Market Share by Type (2019-2030)
Figure 17. Human Vaccine Picture
Figure 18. Veterinary Vaccine Picture
Figure 19. Global Vaccine Adjuvants Sales by Application (2019 VS 2023 VS 2030) & (MT)
Figure 20. Global Vaccine Adjuvants Sales Market Share 2019 VS 2023 VS 2030
Figure 21. Global Vaccine Adjuvants Sales Market Share by Application (2019-2030)
Figure 22. Global Vaccine Adjuvants Revenue by Application (2019 VS 2023 VS 2030) & (MT)
Figure 23. Global Vaccine Adjuvants Revenue Market Share 2019 VS 2023 VS 2030
Figure 24. Global Vaccine Adjuvants Revenue Market Share by Application (2019-2030)
Figure 25. North America Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 26. North America Vaccine Adjuvants Sales Market Share by Country (2019-2030)
Figure 27. U.S. Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 28. Canada Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 29. Europe Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 30. Europe Vaccine Adjuvants Sales Market Share by Country (2019-2030)
Figure 31. Germany Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 32. France Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 33. U.K. Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 34. Italy Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 35. Netherlands Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 36. Asia Pacific Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 37. Asia Pacific Vaccine Adjuvants Sales Market Share by Country (2019-2030)
Figure 38. China Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 39. Japan Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 40. South Korea Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 41. Southeast Asia Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 42. India Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 43. Australia Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 44. LAMEA Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 45. LAMEA Vaccine Adjuvants Sales Market Share by Country (2019-2030)
Figure 46. Mexico Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 47. Brazil Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 48. Turkey Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 49. GCC Countries Vaccine Adjuvants Sales and Growth Rate (2019-2030) & (MT)
Figure 50. Global Vaccine Adjuvants Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Global Vaccine Adjuvants Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 52. North America Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Figure 53. North America Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 54. Europe Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Figure 55. Europe Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 56. Asia-Pacific Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Figure 57. Asia-Pacific Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 58. LAMEA Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Figure 59. LAMEA Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 60. Vaccine Adjuvants Value Chain
Figure 61. Manufacturing Cost Structure
Figure 62. Vaccine Adjuvants Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Years Considered
Figure 66. Research Process
Figure 67. Key Executives Interviewed
